Клеточные и молекулярные механизмы патогенеза иммуновоспалительных ревматических заболеваний
Шрифт:
106. Miyabe Y., Lian, J., Miyabe, C., Luster, A. D. Chemokines in rheumatic diseases: pathogenic role and therapeutic implications. Nature Reviews Rheumatology, 2019, 15:731–46. doi:10.1038/s41584–019–0323–6.
107. Moghaddas F., Masters S. L. Monogenic autoinflammatory diseases: cytokinopathies. Cytokine, 2015, Vol. 74, no.2, pp.237–246. doi: 10.1016/j.cyto.2015.02.012.
108. Moore B. B., Keane M. P., Addison C. L., Arenberg D. A., Strieter R. M., CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J. Invest. Med., 1998, Vol. 46, p. 113.
109. Murphy G., Knauper V., Atkinson S., Butler G., English W, Hutton M., Stracke J., Clark I. Matrix metalloproteinases in arthritic disease. Arthritis Res., 2002, 4(Suppl 3):S39–S49. doi: 10.1186/ar572.
110. Murshid A., Gong J., Calderwood S. K. The role of heat shock proteins in antigen cross presentation. Front. Immunol., 2012, Vol.3, Article63. doi: 10.3389/fimmu.2012.00063. eCollection.
111. Nakhasi H. L., Ramanujam M., Atreya C. D., Hobman T. C., Lee N. Rubella virus glycoprotein interaction with the endoplasmic reticulum calreticulin and calnexin. Arch. Virol., 2001, Vol. 146, pp.1–14.
112. Nanki T., Hayashida K., El-Gabalawy H., Suson S., Shi K., Girschick H. J., Yavus S., Lipsky P. E. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T-cell accumulation in rheumatoid arthritis synovium. J Immunol., 2000, Vol. 165, no. 11, pp. 6590–6598. doi: 10.4049/jimmunol.165.11.6590.
113. Nanki T., Shimaoka T., Hayashida K., Taniguchi K., Yonehara S., Miyasaka N.. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum., 2005, Vol. 52, no.10, pp. 3004–3014. doi: 10.1002/art.21301.
114. Ohtani H. Granuloma cells in chronic inflammation express CD205 (DEC205) antigen and harbor proliferating T lymphocytes: Similarity to antigen-presenting cells. Pathology International, 2013, Vol. 63, pp. 85–93. doi:10.1111/pin.12036.
115. Orr C., Najm A., Biniecka M., McGarry T., Ng C. T., Young F., Fearon U., Veale D. J.. Synovial immunophenotype and anti-citrullinated peptide antibodies in rheumatoid arthritis patients: relationship to treatment response and radiologic prognosis. Arthr. Rheumatol., 2017, Vol. 69, no. 11, pp.2114–2123. doi: 10.1002/art. 40218.
116. Pagan A. J., Ramakrishnan L. The Formation and Function of Granulomas. Annu. Rev. Immunol., 2018, 36:23.1–23.27. https://doi.org/10.1146/annurev- immunol- 032712- 100022.
117. Page C., Francois C., Goeb V., Duverlie G. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. J. Clin. Virol., 2015, Vol. 72, pp.69–74.
118. Pap T., Shigeyama Y., Kuchen S., Fernihough J. K., Simmen B., Gay R. E. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum., 2000, Vol. 43, no. 6, pp.1226–1232. doi: 10.1002/1529–0131(200006)43:6<1226::AID-ANR5>3.0.CO;2–4.
119. Patel D. D., Zachariah J. P., Whichard L. P. CXCR3 and CCR5 ligands in the rheumatoid arthritis synovium. Clin. Immunol., 2001, Vol. 98, no.1, pp. 39–45. doi: 10.1006/clim.2000.4957.
120. Pisetsky D. S., Erlandsson-Harris H., Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Research & Therapy, 2008, 10:209. doi:10.1186/ar2440.
121. Pitzalis C., Kelly S., Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Curr Opin Rheumatol., 2013, Vol. 25, no.3, pp. 334–344. doi: 10.1097/BOR.0b013e32835fd8eb.
122. Randen, I., Mellbye, O. J., Forre, O., Natvig, J. B. The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue. Scand. J. Immunol., 1995, Vol.41, no. 5, pp. 481–486. doi: 10.1111/j.1365–3083.1995.tb03596.x.
123. Raychaudhuri S., Sandor C., Stahl E. A., Freudenberg J., Lee H.S….de Bakker P. I. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet., 2012, Vol. 44, no.3, pp.291–296. doi: 10.1038/ng.1076.
124. Reglero-Real N., Colom B., Bodkin J. V., Nourshargh S. et al. Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation. Arterioscler Thromb Vasc Biol., 2016, Vol. 36, no.10, pp. 2048–2057. doi: 10.1161/ATVBAHA.116.307610.
125. Rizzo C., Grasso G., Castaniti G., Ciccia F., Guggino G. Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation. Vaccines, 2020, Vol. 8, no.2, pp.1–23. doi:10.3390/vaccines8020272.
126. Rock K. L., Kono H. The Inflammatory Response to Cell Death. Annu. Rev. Pathol. Mech. Dis., 2008, Vol. 3, pp.99–126. doi:10.1146/annurev.pathmechdis.3.121806.151456.
127. Rogers G. L., Shirley J. L., Zolotukhin I., Kumar S.P, Sherman A., Perrin G.Q…..Herzog R. W.. Plasmacytoid and conventional dendritic cells cooperate in cross-priming AAV capsid-specific CD8+ T cells. Blood, 2017, Vol. 129, no.24 pp.3184–3195. doi: 10.1182/blood-2016–11–751040.
128. Romero V., Fert-Bober J., Nigrovic P. A., Darrah E., Haque U. J., Lee D. M., van Eyk J., Rosen A., Andrate F. Immune-mediated pore- forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci. Transl. Med., 2013, Vol. 5, 209ra150. doi: 10.1126/scitranslmed.3006869.
129. Rosen A., Casciola-Rosen L. Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases. Annu. Rev. Immunol., 2016, 34:15.1–15.26. doi: 10.1146/annurev-immunol-032414–112205.